oseltamivir phosphate

Poland

Drugs containing this active substance

  • GRIPTAVIR MED

    The medicine is used to treat influenza in adults, adolescents, children, and infants. It may also be used to prevent influenza (e.g., after contact with an infected person) or as preventive treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate No input provided

    ATC: J05AH02

    Manufacturer: HASCO-LEK S.A. Pharmaceutical Production Enterprise

  • The medicine is used to treat influenza in adults, adolescents, children, and infants. It may also be used to prevent influenza or as preventive treatment in exceptional circumstances, e.g., during a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 39.4 mg

    ATC: J05AH02

    Manufacturer: Pharmadox Healthcare Ltd., STADA Arzneimittel AG

  • The medicine is used in adults, adolescents, children, and infants for the treatment of influenza and for the prevention of influenza (e.g., after contact with an infected person). It may also be used as prophylactic treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 59.1 mg

    ATC: J05AH02

    Manufacturer: Pharmadox Healthcare Ltd., STADA Arzneimittel AG

  • The medicine is used in adults, adolescents, children, and infants to treat influenza or to prevent its occurrence (e.g., after contact with an infected person). It may also be used as preventive treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 98.5 mg

    ATC: J05AH02

    Manufacturer: Pharmadox Healthcare Ltd., STADA Arzneimittel AG

  • The medicine is used in adults, adolescents, and children over 6 years of age (weighing more than 40 kg) to treat influenza, to prevent its occurrence after contact with an infected person, or as preventive treatment in exceptional circumstances, e.g., during a pandemic.

    Form: tablets

    Active substance Dosage
    oseltamivir phosphate 98.5 mg

    ATC: J05AH02

    Manufacturer: Biofarm Sp. z o.o.

  • The medicine is used to treat influenza in adults, adolescents, children, and infants. It may also be used for the prevention of influenza (e.g., after contact with a sick person) or as prophylactic treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 39.4 mg

    ATC: J05AH02

    Manufacturer: Balkanpharma-Razgrad AD

  • The medicine is used in adults, adolescents, children, and infants for the treatment of influenza. It may also be used for the prevention of influenza (e.g., after contact with a sick person) or as preventive treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 59.1 mg

    ATC: J05AH02

    Manufacturer: Balkanpharma-Razgrad AD

  • The medicine is used in adults, adolescents, children, and infants for the treatment of influenza. It may also be used for the prevention of influenza (e.g., after contact with a sick person) or as preventive treatment in exceptional situations, such as a pandemic.

    Form: capsules, hard

    Active substance Dosage
    oseltamivir phosphate 98.5 mg

    ATC: J05AH02

    Manufacturer: Balkanpharma-Razgrad AD

  • The medicine is used in adults, adolescents, and children over 6 years of age (weighing more than 40 kg) for the treatment of influenza, the prevention of its occurrence, or as prophylactic treatment in exceptional situations, e.g., during a pandemic.

    Form: tablets, film-coated

    Active substance Dosage
    oseltamivir phosphate 98.5 mg

    ATC: J05AH02

    Manufacturer: Medicofarma S.A.